DK127507B - Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.

Info

Publication number
DK127507B
DK127507B DK25372A DK25372A DK127507B DK 127507 B DK127507 B DK 127507B DK 25372 A DK25372 A DK 25372A DK 25372 A DK25372 A DK 25372A DK 127507 B DK127507 B DK 127507B
Authority
DK
Denmark
Prior art keywords
preparation
acid addition
addition salts
analogous process
benzodiazepine compounds
Prior art date
Application number
DK25372A
Other languages
Danish (da)
English (en)
Inventor
E Reeder
A Stempel
L Sternbach
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US240750A external-priority patent/US3340253A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK127507B publication Critical patent/DK127507B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK25372A 1962-03-09 1972-01-18 Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf. DK127507B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17855162A 1962-03-09 1962-03-09
US240750A US3340253A (en) 1962-11-28 1962-11-28 Preparation of certain benzodiazepine compounds

Publications (1)

Publication Number Publication Date
DK127507B true DK127507B (da) 1973-11-19

Family

ID=26874429

Family Applications (1)

Application Number Title Priority Date Filing Date
DK25372A DK127507B (da) 1962-03-09 1972-01-18 Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.

Country Status (9)

Country Link
BE (1) BE629227A (de)
CA (1) CA976547A (de)
CH (2) CH457464A (de)
DE (4) DE1545955A1 (de)
DK (1) DK127507B (de)
ES (1) ES285854A1 (de)
GB (2) GB1013900A (de)
NL (3) NL7010711A (de)
SE (2) SE328583B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES405260A1 (es) * 1972-07-28 1975-07-01 Stabilimenti Chim Farmac Riuni Procedimiento para la preparacion de 3-hidroxi-5-aril-7- sustituidos-1, 3-dihidro-2h-1, 4-benzodiacepin-2-onas.
NL173269C (nl) * 1974-04-30 1984-01-02 Ferrer Int Werkwijze voor de bereiding van een geneesmiddel met als werkzaam bestanddeel een 1,4-benzodiazepinederivaat, alsmede werkwijze voor de bereiding van het 1,4-benzodiazepinederivaat.
DE3413592C2 (de) * 1984-04-11 1986-06-05 Dolorgiet GmbH & Co KG, 5205 St Augustin Arzneimittel enthaltend 5-(2-Fluorphenyl)-1,3-dihydro-3-hydroxy-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-on
ES8609278A1 (es) * 1984-06-26 1986-09-01 Merck & Co Inc Un procedimiento para la preparacion de analogos de benzodiazepina.

Also Published As

Publication number Publication date
DE1445873A1 (de) 1969-04-10
DE1545957A1 (de) 1969-12-11
GB1013229A (en) 1965-12-15
NL7010712A (de) 1970-10-26
CH442326A (de) 1967-08-31
ES285854A1 (es) 1963-08-16
SE361174B (de) 1973-10-22
CA976547A (en) 1975-10-21
NL289735A (de)
DE1545955A1 (de) 1969-11-20
NL7010711A (de) 1970-10-26
DE1545956A1 (de) 1969-11-20
SE328583B (de) 1970-09-21
CH457464A (de) 1968-06-15
GB1013900A (en) 1965-12-22
BE629227A (fr) 1963-10-21

Similar Documents

Publication Publication Date Title
DK108497C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner eller syreadditionssalte deraf.
DK115999B (da) Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf.
DK109037C (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf.
DK109779C (da) Fremgangsmåde til fremstilling af 3-aminopyrazinamidoguanidinforbindelser eller syreadditionssalte heraf.
DK117000B (da) Fremgangsmåde til fremstilling af substituerede phenylamino-1,3-diazacyclopentener-(2) eller syreadditionssalte heraf.
DK115851B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-4-aryl-quinazoliner eller syreadditionssalte deraf.
DK127507B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK118657B (da) Analogifremgangsmåde til fremstilling af 3',4',5'-trimethoxy-3-aminoacrylophenoner eller syreadditionssalte deraf.
DK115771B (da) Fremgangsmåde til fremstilling af (3,5-diamino-6-halogenpyrazinoyl) guanidin- eller (3,5-diamino-6-halogenpyrazinamido) guanidin-forbindelser eller syreadditionssalte deraf.
DK104408C (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK105472C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK112449B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf.
DK107100C (da) Fremgangsmåde til fremstilling af fluorsubstituerede 7-nitro-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK105025C (da) Fremgangsmåde til fremstilling af umættede 9,10-dihydro-10,10,-dimethylanthracenderivater eller syreadditionssalte deraf.
DK106381C (da) Fremgangsmåde til fremstilling af 2-dimethylamino-3,5,6-trimethylpyrazin eller syreadditionssalte heraf.
DK101976C (da) Fremgangsmåde til fremstilling af 1,2,3,4,4a,5,6,10b-octahydro-phenanthridinforbindelser eller syreadditionssalte deraf.
DK118667B (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-5-phenyl-2H-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK113651B (da) Fremgangsmåde til fremstilling af 6,11-dihydro-11-(3-alkylaminopropyl)-dibenzo-[b,e]thiepiner eller syreadditionssalte deraf.
DK106911C (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-aryl-1H-1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK106093C (da) Fremgangsmåde til fremstilling af 2-pyrrolidino-1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK108726C (da) Fremgangsmåde til fremstilling af 1,3-dihydro-5-pyridyl-7-trifluormethyl-2H-1,4-benzodiazepin-2-oner eller syreadditionssalte deraf.
DK97033C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK110120C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK99638C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK94315C (da) Fremgangsmåde til fremstilling af fluorholdige 1,4-benzodiazepinforbindelser eller syreadditionssalte deraf.